Wedbush Securities’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Wedbush Securities’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,550	Closed	–	–	925
2016 Q3	$0	Sell	10,550 -700	-6%	-$171	﹤0.01%	908
2016 Q2	$5K	Sell	11,250 -2,000	-15%	-$3.21K	﹤0.01%	785
2016 Q1	$36K	Hold	13,250	–	–	0.01%	708
2015 Q4	$41K	Hold	13,250	–	–	0.01%	690
2015 Q3	$59K	Hold	13,250	–	–	0.01%	656
2015 Q2	$76K	Buy	13,250 +1,950	+17%	+$13.3K	0.01%	672
2015 Q1	$101K	Buy	+11,300	New	+$90.8K	0.02%	664

Wedbush Securities's EPRS Position: Q4 2016 in Review

Wedbush Securities sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q4 2016, closing a stake of 10,550 shares.

Wedbush Securities first reported a position in EPRS in Q1 2015 and held it in 7 quarters. The position peaked at $101K in Q1 2015. 1 fund tracked by Wall St. Rank holds EPRS as of Q4 2016.

Wedbush Securities reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q4 2016 after selling out during the quarter.
Wedbush Securities sold 10,550 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q4 2016.
Wedbush Securities first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 7 quarters.
Wedbush Securities's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $101K in Q1 2015.
1 fund tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q4 2016.

Based on Wedbush Securities's 13F filing for Q4 2016, filed 25 Jan 2017.